Radiopharmacy firm Medi-Physics has signed a deal with Fujisawato distribute its Adenoscan pharmacological stress agent, whichreceived Food and Drug Administration approval in May. Fujisawalicenses the agent from Medco Research. Medi-Physics, a
Radiopharmacy firm Medi-Physics has signed a deal with Fujisawato distribute its Adenoscan pharmacological stress agent, whichreceived Food and Drug Administration approval in May. Fujisawalicenses the agent from Medco Research.
Medi-Physics, a subsidiary of Amersham International, willdistribute Adenoscan through its network of 115 radiopharmacies.Medi-Physics, of Arlington Heights, IL, hopes to achieve synergiesbetween Adenoscan and its Myoview technetium-based cardiac imagingagent, which received an approvable letter from the Food and DrugAdministration last month (SCAN 8/2/95).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.